Antibody Testing Market
Market Study on Antibody Testing: Serological Test Kits to Remain Highly Popular
Antibody Testing Market Segmented By Serological Test Kit, Immunoglobulin Kits, Lateral Flow Assay Kits, Chemicals and Reagents, Consumables Product with Pregnancy, Cardiovascular Disease, Autoimmune Disease, Infectious Disease, Oncology, Endocrine Disease, Diabetes Indication
Global demand for antibody testing is set to experience significant growth at 7.7% CAGR from 2021 to 2031, up from a market value of around US$ 7.4 Bn in 2021. As per Persistence Market Research’s projections, serological test kits held a substantial market share of 34.8% in 2020. Antibody testing market value holds around 26% share in the overall molecular diagnostics market.
Antibody Testing Market Value (2020)
US$ 6.9 Bn
Forecasted Global Market Value (2031)
US$ 15.6 Bn
Market Growth Rate (2021-2031)
Share of Top 5 Countries
Find Out More about the Report Coverage
- Thermo Fisher Scientific
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Beckton, Dickinson and Company
- F. Hoffmann-La Roche
- Agilent Technologies
- Zeus Scientific
- Abcam PLC
- Trinity Biotech
- Werfen (Biokit)
- Meridian Bioscience
- Bio-Techne (R&D Systems)
Sales Analysis of Antibody Testing from 2016 to 2020 Vs Market Outlook for 2021 to 2031
Antibody-based test kits, also known as immunoassays, are biochemical methods that use the specificity of an antibody-antigen reaction to identify and measure target biomolecules in samples such as blood, serum, plasma or urine.
The principle behind antibody-based test kits is the biochemical interaction between antibody and antigen. Antibodies have the ability to recognize and bind to a specific macromolecule. The test kits employ this to identify the foreign antigen present in the sample.
Antibody-based test kits come in various types. Some kits can be easy-to-use kits such as lateral flow assay kits, while other could employ more sophisticated techniques such as ELISA or chemiluminescence immunoassays. Other immunoassays are radioimmunoassay, fluoroimmunoassay, and others.
These methods are frequently used in clinical diagnostics, drug discovery, drug monitoring, and food testing. The global market for antibody testing expanded at 5% CAGR over the past 5 years, and is expected to expand at a considerable CAGR of 7.7% through 2031.
Customize this Report
Explore Intelligence Tailored to Your Business Goals.
What are the Key Opportunities for Antibody Testing Product Manufacturers?
Recent breakthroughs in developing biomarkers specific to conditions have opened a window of opportunities for the antibody-based testing market. For example, technological advancements in proteomics, genomics, and metabolomics help researchers to fine tune cancer diagnostics and their subtypes based on the molecular defects they possess. Diagnostics tools based on these biomarkers are set to spur the growth of the testing market.
Development of condition-specific biomarkers can also benefit companies by developing a final diagnostic kit that is better in terms of specificity, usability, sensitivity, cost, required logistics, and in due course, health outcomes. These developments have led to unleashing a vast foray of indications where antibody-based test kits can be used.
Diagnostics laboratories form a pivot point for healthcare services, research, and development. Demand for tests is ever-increasing due to the growing prevalence of chronic diseases, rising geriatric population, and the general population. This demands quick results without compromising on quality, which means more adoption of laboratory automation.
Antibody based-test kits have been utilized vastly due to their ability to detect a large number of biomolecules that are relevant in clinical diagnostics and therapeutic research. Recent developments of multi-analyte immunoassays have widened the horizon for indications of immunoassays.
Microfluidics immunoassays hold the potential of measuring protein-based biomarkers in miniaturized test kits, thereby expanding the scope of antibody-based test kits.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
Which Factors are Restraining Demand for Antibody Testing?
Most governments, through the dedicated regulatory authorities in their respective countries, impose regulations on pharmaceutical and medical devices to protect their population from substandard products. These regulations prolong the launching of new products, hindering the growth of the market.
The trial periods for medical products are long, making the entire process highly cost-intensive. Adding to these expenses will be the compliance needed for new regulatory programs.
For instance, manufacturers will have to change their processes of quality management to comply with the Medical Device Single Audit Program (MDSAP), which could be a monetary challenge in an already expensive scenario.
Furthermore, developers of novel diagnostics do not have clarity on the reimbursement scenario in terms of clinical trial requirements and optimal outcome measure. These uncertainties keep healthcare providers from ordering novel diagnostic test kits, thereby limiting market growth to some extent.
Explore Persistence Market Research’s expertise in promulgation of the business !
Why Does the U.S. Lead the Global Market for Antibody Testing?
The U.S. dominates the North American region with a market share of around 94.3%, and is projected to continue experiencing high growth throughout the forecast period.
Growth of this market is driven by an established and growing healthcare system and the presence of major players in the antibody testing industry in the country.
Why is the U.K. Considered a Lucrative Market for Antibody Testing in Europe?
The U.K. dominates the European market for antibody testing with a share of over 21%. Germany possesses considerable institutional funding for research & development, due to which, the quality of research has intensified in the European region.
Establishment of regulatory guidelines in the U.K. for in-vitro diagnostics additionally contributes to the growth of antibody testing in the market.
Why is China an Emerging Market for Antibody Testing?
China holds close to 50% share in the East Asia market, which is projected to increase over the forecast period. The Chinese market for antibody testing experienced rising demand through the advent of the COVID-19 pandemic. This growth is supported by China investing 15% of its revenue in research & development activities.
Why is Demand for Serological Test Kits High?
By product, serological test kits project a high CAGR of 9.7% through the forecast period. This high growth is associated with wide indications of immunoassays such as quality control checks, therapeutic diagnostics, and research and drug development, to name a few.
Which End User Drive Most Sales of Antibody Testing Products?
Based on end user, diagnostic laboratories lead the antibody-based testing space with 33.6% market share. Increasing research in this field is responsible for a high segment share in the market.
Impact of COVID-19
With growing disease outbreaks and frequent epidemics, the need for easy-to-use antibody-based test kits will continue to grow at a steady pace. This is clear from the fact that demand for COVID-19 test kits will not shrink in the near future owing to newly discovered cases of reinfection together with cases of first-time infection.
Governments all over the world are trying their best to deal with the pandemic, which requires aggressive testing to stop the spread of the infection. Constant efforts by pharmaceutical companies to develop and launch new products, either by improving existing ones or coming up with entirely new products, is one of the significant drivers for the market. Companies have impressive pipelines that look promising for the near future growth of the market.
- For instance, EUROIMMUN displayed its newest innovations in the diagnostic field during the world’s biggest trade fair in November 2019.
- In February, 2020, in the U.K., RMDM launched a blood test kit called PanTum Detect to detect cancer in early stages.
- More recently, in August 2020, Transasia Bio-Medicals launched a test kit called ErbaLisa COVID-19 IgG ELISA in the emerging Indian market.
The strategy of expansion, new product launches, and approvals by key manufacturers is strengthening their market presence.
- In April 2020, Abbott launched the third test kit for detecting COVID-19. It is a laboratory-based blood test.
- In March 2020, Bio-Rad Laboratories, Inc. launched the SARS CoV-2 standard, which would support validation of laboratory assays of coronavirus (COVID-19) antibody testing.
Similarly, recent developments related to companies manufacturing antibody (serology) testing products have been tracked by the team at Persistence Market Research, which are available in the full report.
Antibody Testing Industry Report Scope
Historical Data Available for
US$ Mn for Value
Key Regions Covered
Key Countries Covered
Key Market Segments Covered
Key Companies Profiled
Available upon Request
Key Segments Covered in Antibody Testing Industry Research
- Serological Test Kits
- Serological Assay Test Kits
- Serological Rapid Assay Kits
- Immunoglobulin Kits
- Immunoglobulin Assay Test Kits
- Immunoglobulin Rapid Assay Kits
- Lateral Flow Assay Kits
- Lateral Flow Assay Test Kits
- Lateral Flow Rapid Assay Kits
- Serological Test Kits
- Chemical and Reagents
- Cardiovascular Diseases
- Autoimmune Diseases
- Infectious Diseases
- Endocrine Diseases
By End User
- Academic and Research Institutes
- Diagnostic Laboratories
- Biopharmaceutical Companies
- Homecare Settings
- FAQs -
The global antibody testing market is worth US$ 6.9 Bn at present, and is set to expand 2.3X over the next ten years.
Sales of antibody testing products are expected to reach US$ 15.6 Bn by the end of 2031, at an expected 7.7% CAGR.
From 2016-2020, demand for antibody testing expanded at the rate of 5% CAGR.
Rising demand of antibody home testing/self-testing, rising focus on e-Commerce sales, and transition from lab-based testing to disposable point-of-care testing at medical facilities are key trends being witnessed in this marketplace.
The U.S., China, U.K., Germany, and Russia are expected to drive most demand for antibody testing products.
North America is one of the key markets for antibody testing, with the U.S. expected to account 94.9% of the North American market.
Demand for antibody testing in Europe is expected to register growth at 7.4% CAGR over the next ten years.
The U.S., China, and U.K. are key producers of antibody testing products.
China appears to uphold a share of close to 50% in East Asia, while Japan holds a revenue share of 35.5%.